These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 11870871)

  • 1. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS.
    Hughes PM; Botham MS; Frentzel S; Mir A; Perry VH
    Glia; 2002 Mar; 37(4):314-27. PubMed ID: 11870871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractalkine expression in the rhesus monkey brain during lentivirus infection and its control by 6-chloro-2',3'-dideoxyguanosine.
    Depboylu C; Eiden LE; Schäfer MK; Reinhart TA; Mitsuya H; Schall TJ; Weihe E
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1170-80. PubMed ID: 17146291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain.
    Lindia JA; McGowan E; Jochnowitz N; Abbadie C
    J Pain; 2005 Jul; 6(7):434-8. PubMed ID: 15993821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions.
    Verge GM; Milligan ED; Maier SF; Watkins LR; Naeve GS; Foster AC
    Eur J Neurosci; 2004 Sep; 20(5):1150-60. PubMed ID: 15341587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats.
    Milligan ED; Zapata V; Chacur M; Schoeniger D; Biedenkapp J; O'Connor KA; Verge GM; Chapman G; Green P; Foster AC; Naeve GS; Maier SF; Watkins LR
    Eur J Neurosci; 2004 Nov; 20(9):2294-302. PubMed ID: 15525271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.
    Fang IM; Lin CP; Yang CM; Chen MS; Yang CH
    Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation.
    Zujovic V; Benavides J; Vigé X; Carter C; Taupin V
    Glia; 2000 Feb; 29(4):305-15. PubMed ID: 10652441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
    Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE
    Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
    Lucas AD; Bursill C; Guzik TJ; Sadowski J; Channon KM; Greaves DR
    Circulation; 2003 Nov; 108(20):2498-504. PubMed ID: 14581400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA.
    Melton LM; Keith AB; Davis S; Oakley AE; Edwardson JA; Morris CM
    Glia; 2003 Oct; 44(1):1-12. PubMed ID: 12951652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
    Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
    Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.
    Hasegawa M; Sato S; Echigo T; Hamaguchi Y; Yasui M; Takehara K
    Ann Rheum Dis; 2005 Jan; 64(1):21-8. PubMed ID: 15608300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
    Damås JK; Boullier A; Waehre T; Smith C; Sandberg WJ; Green S; Aukrust P; Quehenberger O
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2567-72. PubMed ID: 16224053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
    Bjerkeli V; Damås JK; Fevang B; Holter JC; Aukrust P; Frøland SS
    Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractalkine and fractalkine receptors in human neurons and glial cells.
    Hatori K; Nagai A; Heisel R; Ryu JK; Kim SU
    J Neurosci Res; 2002 Aug; 69(3):418-26. PubMed ID: 12125082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine.
    Combadiere C; Gao J; Tiffany HL; Murphy PM
    Biochem Biophys Res Commun; 1998 Dec; 253(3):728-32. PubMed ID: 9918795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
    Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
    J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine.
    Milligan E; Zapata V; Schoeniger D; Chacur M; Green P; Poole S; Martin D; Maier SF; Watkins LR
    Eur J Neurosci; 2005 Dec; 22(11):2775-82. PubMed ID: 16324111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CX3CL1-CX3CR1 system and psoriasis.
    Plant D; Young HS; Watson RE; Worthington J; Griffiths CE
    Exp Dermatol; 2006 Nov; 15(11):900-3. PubMed ID: 17002687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.